WHO Extends Crucial Pandemic Treaty Talks as Global Negotiations Enter Final Phase

WHO Director-General Dr Tedros Adhanom Ghebreyesus emphasized the centrality of the mechanism, calling it essential to rebuilding trust and ensuring solidarity in future global health emergencies.

In a significant development for global health governance, World Health Organization (WHO) Member States have agreed to extend negotiations on a critical component of the Pandemic Agreement—the Pathogen Access and Benefit Sharing (PABS) system—pushing high-stakes discussions into late April ahead of a decisive vote at the World Health Assembly (WHA) in May.

The move underscores both the urgency and complexity of finalizing one of the most consequential international health frameworks since COVID-19, as countries work to reconcile competing priorities around equity, sovereignty, and rapid scientific cooperation.

A Core Pillar of the Pandemic Agreement

The PABS annex is widely regarded as the backbone of the WHO Pandemic Agreement, designed to correct systemic failures exposed during the COVID-19 crisis—particularly inequities in access to vaccines, diagnostics, and life-saving treatments.

At its core, the system aims to establish:

• Rapid, transparent sharing of pathogens with pandemic potential

• Fair and equitable distribution of benefits derived from their use

• A structured framework linking scientific collaboration with public health equity

WHO Director-General Dr Tedros Adhanom Ghebreyesus emphasized the centrality of the mechanism, calling it essential to rebuilding trust and ensuring solidarity in future global health emergencies.

“The Pathogen Access and Benefit Sharing system lies at the heart of the WHO Pandemic Agreement,” he said, urging countries to overcome divisions and prioritize collective global health security.

Negotiations Intensify Under Tight Timeline

Formal negotiations will resume from 27 April to 1 May, with additional informal consultations scheduled in the coming weeks. The extended timeline reflects the reality that several technically complex and politically sensitive issues remain unresolved.

Key areas under negotiation include:

• Definition of “benefits”: What constitutes fair returns—vaccines, intellectual property access, technology transfer, or financial contributions

• Distribution mechanisms: How benefits will be allocated across countries, particularly low- and middle-income nations

• Contractual frameworks: Legal structures governing pathogen sharing between countries, laboratories, and pharmaceutical entities

• Governance systems: Oversight mechanisms to ensure transparency, compliance, and accountability

Negotiators working under the WHO’s Intergovernmental Working Group (IGWG) have described the talks as “intensive,” reflecting the high stakes involved.

Balancing Equity and Sovereignty

One of the most contentious aspects of the PABS system is balancing national sovereignty over biological resources with the need for rapid global data sharing during outbreaks.

Developing countries have pushed for stronger guarantees that sharing pathogens will not repeat the inequities seen during COVID-19, when many nations faced delayed or limited access to vaccines despite contributing critical data.

At the same time, some countries and industry stakeholders are seeking clarity on intellectual property protections and operational feasibility.

Ambassador Tovar da Silva Nunes of Brazil, Co-Chair of the IGWG Bureau, highlighted the ambition of negotiators to deliver a system that is both equitable and workable.

A Race Against the World Health Assembly Deadline

With less than two months remaining before the World Health Assembly convenes in May, negotiators are under pressure to finalize the PABS annex in time for adoption alongside the broader Pandemic Agreement.

UK Co-Chair Matthew Harpur acknowledged progress but noted that “additional time is needed to bridge remaining differences,” signaling that while momentum exists, consensus is not yet guaranteed.

Learning from COVID-19’s Failures

The broader WHO Pandemic Agreement—adopted last year—was designed to address critical gaps revealed during the COVID-19 pandemic, including:

• Fragmented global coordination

• Delays in data and pathogen sharing

• Inequitable access to vaccines and medical countermeasures

• Weak preparedness systems in many regions

The PABS system is intended to directly tackle these issues by embedding equity into the earliest stages of outbreak response.

Global Implications

If successfully adopted, the PABS framework could reshape how the world responds to future pandemics by:

• Accelerating scientific collaboration and outbreak detection

• Ensuring faster development and distribution of medical countermeasures

• Strengthening trust between nations, particularly between high-income and developing countries

• Creating a more predictable and rules-based global health system

Public health experts note that the outcome of these negotiations will likely define international pandemic governance for decades.

Commitment to Multilateralism

Despite ongoing disagreements, WHO Member States reaffirmed their commitment to multilateral cooperation, solidarity, and equity—principles seen as essential to managing transnational health threats.

The decision to extend negotiations rather than rush an incomplete agreement reflects a strategic choice: prioritizing a robust, consensus-driven framework over speed alone.

As talks resume in April, the global health community will be watching closely. The success—or failure—of the PABS negotiations could determine whether the world is better prepared for the next pandemic, or risks repeating the inequities of the last.